Inhibition of NF-κB pathway by MG132, or sulfasalazine dramatically diminishes resistance to apoptosis induced by gemcitabine in multiple pancreatic cancer cell lines [5]. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.